Atlas Trials

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.

Clinical trial NCT02925702 · UNKNOWN

Trial details

NCT number
NCT02925702
Sponsor
Centro Nacional de Investigaciones Oncologicas CARLOS III
Status
UNKNOWN
Study type
OBSERVATIONAL
Advanced Prostate CancerCastration ResistantRadium 223
Start date
2016-02-01
Primary completion
2019-01-01
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.